DRAXIS Health (DRAX) in Discussions Regarding Potential Transaction That Could Lead to Sale of the Company
More News related to DRAX
- Jesup & Lamont Downgrades Draxis Health (DRAX) to Neutral
- Unusual 11 Mid-Day Movers 4/4: DRAX, COCO, MEE, JASO Higher; OFIX, DMAN, TGIC, BCSI Lower
- DRAXIS Health (DRAX) Resumes Trading -Bloomberg
- DRAXIS (DRAX) To Be Acquired By Jubiliant for $255M
- DRAXIS Health (DRAX) in Discussions Regarding Potential Transaction That Could Lead to Sale of the Company
More News related to Hot List
- After-Hours Movers 11/30: GES, ALTR Higher; NLST, CUTR, LTON, OVTI Lower
- Trading Radar for 12/1: Staples (SPLS), Universal Tech (UTI), Beacon Roofing (BECN) Report
- Unusual 11 Mid-Day Movers 11/30: SOMX, CLWT, KBX, CSGS Higher; AIG, BGP, BONT, HEB Lower
- Notable ETF Movers: SLX, EWJ, USO Higher; UNG, XRT Lower
- Best of the Web 11/30: Some Banks So Bad Buyers Won't Touch 'Em, Risky Bets Hurt Harvard, Eurozone Inflation Turns Positive
DRAXIS Health Inc. (NASDAQ: DRAX), in response to a request by securities regulators with respect to increased trading in its common stock, announced today that it is currently in exclusive discussions regarding a potential transaction that could lead to a sale of the Company. There can be no certainty at this stage that these discussions will continue or result in any agreement or transaction or result in pricing that will be acceptable either to the board of directors of the Company or to shareholders.
DRAXIS Health Inc. (DRAXIS) is a specialty pharmaceutical company providing products in three categories: sterile products, non-sterile products and radiopharmaceuticals.
Related Categories
Hot ListMergers and Acquisitions
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
